Galapagos has changed its name to Lakefront Biotherapeutics. This page will remain live for continuity during the transition. For all future Company updates, please follow our official new LinkedIn page: https://www.linkedin.com/company/lakefront-bio
| Website | http://www.glpg.com |
| Revenue | $267.9 million |
| Employees | 538 (246 on RocketReach) |
| Founded | 1999 |
| Phone | +32 15 34 29 00 |
| Industry | Biotechnology Research |
| Competitors | Vertex Pharmaceuticals, Pfizer, AstraZeneca, Novartis, Boehringer Ingelheim, AbbVie, Roche, Gilead Sciences, Receptos, a wholly-owned subsidiary of Celgene, Amgen +50 more (view full list) |
Looking for a particular Galapagos employee's phone or email?
The Galapagos annual revenue was $267.9 million in 2026.
Jason Treese is the SVP, Global Head of Quality at Galapagos of Galapagos.
246 people are employed at Galapagos.